Post-Splenectomy Care: 8 Essential Steps to Prevent OPSI
Clinical Practice Update — Splenectomy Indications, Pre-Operative Vaccination, and Lifelong Infection Prevention in Adults
This is an original clinical education article informed by current guidelines and evidence. See References below for source documents.
- Clinical Focus
- Pre-operative immunisations, OPSI counselling, and antibiotic prophylaxis in adult post-splenectomy care
- Target Audience
- General surgeons, primary care physicians, haematologists, infectious disease specialists, residents
- Setting
- Pre-operative clinic, inpatient surgery, primary care follow-up
- Source Evidence
- •BSH Guidelines on Prevention and Treatment of Infection in Patients with Absent or Dysfunctional Spleen (2011)
- •IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host (2014)
- •ACIP Pneumococcal Vaccine Recommendations for Adults — MMWR (2023)
- •ACIP Meningococcal Vaccination Recommendations — MMWR (2020)
- •Theilacker et al. — Asplenia and Risk of Overwhelming Infection (Clin Infect Dis, 2016)
Key Clinical Takeaways
Effective post-splenectomy care rests on three pillars that begin before the operation and continue for life: timely vaccination against encapsulated organisms, antibiotic prophylaxis for selected patients, and patient counselling about overwhelming post-splenectomy infection (OPSI). The lifetime risk of OPSI in asplenic adults sits around 5%, with mortality reaching 50% once sepsis is established — making structured post-splenectomy care one of the highest-yield preventive interventions in surgical practice.
- 1Administer pneumococcal, meningococcal, and Hib vaccines at least 14 days before elective splenectomy whenever possible → Pre-Operative Vaccination
- 2After emergency splenectomy, defer immunisation to day 14 post-operatively to optimise vaccine response → Emergency Splenectomy
- 3Prescribe lifelong daily antibiotic prophylaxis in the first two years post-splenectomy, in children, and in higher-risk adults → Antibiotic Prophylaxis
- 4Issue every asplenic patient a standby antibiotic course for self-administration at the first sign of febrile illness → Standby Antibiotics
- 5Counsel every patient on OPSI warning signs and provide a written action plan before discharge → OPSI Counselling
- 6Boost PPSV23 once at five years; use PCV20 alone or PCV15 followed by PPSV23 for newly diagnosed asplenia → Vaccination Schedule
- 7Cover both meningococcal serogroups: give MenACWY plus MenB, with a MenACWY booster every five years → Meningococcal Cover
- 8Document asplenic status in the medical record and provide a medical alert card or bracelet to every patient → Documentation
When Splenectomy Is Indicated
Splenectomy indications fall into four broad clinical categories: trauma, haematologic disease, malignancy, and rarely splenic abscess or cyst. Recognising the indication matters because it dictates whether vaccination can be planned (elective) or must be given post-operatively (emergency), and whether the underlying disease creates additional immunological vulnerability that shapes downstream post-splenectomy care.
Patients with sickle cell disease, coeliac disease, inflammatory bowel disease, or prior splenic irradiation may have functional asplenia — the spleen is anatomically present but immunologically inert. These patients require the same post-splenectomy care framework as those who have undergone surgical removal.
Common Surgical Indications
Perform splenectomy for refractory immune thrombocytopenia after failure of corticosteroids and a thrombopoietin receptor agonist trial.
Moderate Rec Moderate Evidence ASH 2019Consider splenic preservation (partial splenectomy or splenorrhaphy) wherever feasible in trauma, especially in young patients, to retain residual immune function.
Strong Rec Moderate Evidence WSES Trauma 2017Refer patients with hereditary spherocytosis for splenectomy only when symptomatic anaemia, growth retardation, or recurrent transfusions justify the lifelong infection risk.
Conditional Rec Low Evidence BSH 2011Post-Splenectomy Care Begins Pre-Operatively: Vaccination Strategy
The window before an elective splenectomy is the single highest-yield opportunity in post-splenectomy care. A functioning spleen mounts a far more robust vaccine response than the asplenic state that follows surgery, so timing vaccines correctly can mean the difference between durable protection and an inadequate antibody titre.
Administer pneumococcal vaccination at least 14 days before elective splenectomy. Either give PCV20 as a single dose, or give PCV15 followed by PPSV23 a minimum of 8 weeks later.
Strong Rec High Evidence ACIP MMWR 2023 BSH 2011Give a quadrivalent meningococcal conjugate vaccine (MenACWY) plus a serogroup B meningococcal vaccine (MenB) at least 14 days pre-operatively. Two MenACWY doses 8–12 weeks apart provide optimal priming in asplenia.
Strong Rec Moderate Evidence ACIP MMWR 2020Administer a single dose of Haemophilus influenzae type b (Hib) conjugate vaccine to any adult who has not previously received it.
Strong Rec Moderate Evidence IDSA 2014Ensure the annual inactivated influenza vaccine is up to date, since influenza increases the risk of secondary bacterial pneumonia and sepsis in asplenic patients.
Strong Rec High Evidence CDC 2024Vaccination Schedule by Vaccine Type
| Vaccine | Primary Series in Asplenia | Booster Schedule | Practical Tips |
|---|---|---|---|
| PCV20 (or PCV15 then PPSV23) | Single dose of PCV20, or PCV15 followed by PPSV23 ≥8 weeks later | One PPSV23 booster after 5 years if the PCV15-then-PPSV23 sequence was used | PCV20 simplifies the schedule for adults newly diagnosed with asplenia |
| MenACWY | Two doses, 8–12 weeks apart | Every 5 years lifelong | Set a calendar reminder — missed boosters are the most common gap |
| MenB | Two-dose 4CMenB or three-dose MenB-FHbp series | Booster recommended after 1 year, then every 2–3 years | Use the same MenB product for the whole series — brands are not interchangeable |
| Hib conjugate | Single dose for adults with no prior Hib vaccination | No booster required in adults | Often forgotten in adults — build into the checklist |
| Inactivated influenza | Single annual dose | Annual lifelong | Use inactivated formulations — avoid live attenuated nasal spray |
Vaccination After Emergency Splenectomy
Trauma and emergency splenectomy account for roughly a third of all cases, and these patients arrive in the ward with no pre-operative vaccination plan. The challenge then is timing: vaccinating too early risks a suboptimal antibody response in a peri-operative inflammatory milieu; waiting too long leaves the patient unprotected during the period of highest OPSI vulnerability.
Delay vaccination until day 14 after emergency splenectomy. Initiating the standard pneumococcal, meningococcal, and Hib series at this point optimises immune response without leaving an excessive gap in protection.
Strong Rec Moderate Evidence IDSA 2014 BSH 2011Prescribe antibiotic prophylaxis from the day of discharge to bridge the immunological gap until the post-operative vaccination series is complete.
Strong Rec Moderate Evidence BSH 2011If the patient received rituximab or chemotherapy in the prior 6 months, defer vaccines an additional 3–6 months until B-cell reconstitution allows an adequate response.
Moderate Rec Moderate Evidence IDSA 2014Studies comparing immune response at day 1, day 7, and day 14 post-splenectomy show progressively higher antibody titres with delay. Vaccinating on day 1 (still common practice in some centres) produces protective titres in fewer than half of patients. Day 14 balances reasonable protection with practical discharge timing in post-splenectomy care.
Antibiotic Prophylaxis in Post-Splenectomy Care
Antibiotic prophylaxis sits alongside vaccination as the second main pillar of post-splenectomy care. It splits into two distinct strategies: daily prophylaxis in higher-risk patients and time windows, and standby antibiotics issued to every asplenic patient for self-administration at the first sign of fever.
Prescribe daily phenoxymethylpenicillin (penicillin V) 250–500 mg twice daily, or amoxicillin 250–500 mg daily, for all asplenic patients during the first two years after splenectomy.
Strong Rec Moderate Evidence BSH 2011Continue lifelong daily prophylaxis in children under 16, in patients with prior OPSI, in those with underlying haematological malignancy, and in patients who decline or cannot complete vaccination.
Strong Rec Moderate Evidence BSH 2011Switch to clarithromycin 250 mg daily, or moxifloxacin 400 mg daily, in patients with documented penicillin allergy. Avoid macrolide use if there is a known long QT.
Moderate Rec Low Evidence BSH 2011Issue every asplenic patient a 5–7 day standby course of amoxicillin/clavulanate (or levofloxacin in penicillin allergy) to take at the first sign of fever pending urgent medical review.
Strong Rec Moderate Evidence BSH 2011Antibiotic Choice by Clinical Scenario
| Clinical Scenario | Recommended Drug & Dose | Alternative (Penicillin Allergy) | Practical Considerations |
|---|---|---|---|
| Daily prophylaxis — first 2 years | Penicillin V 250–500 mg BID or amoxicillin 250–500 mg daily | Clarithromycin 250 mg daily | Once-daily dosing improves adherence |
| Lifelong prophylaxis — high-risk patients | Penicillin V 500 mg BID | Clarithromycin 250 mg daily | Review benefit annually; reassess if antibiotic resistance is detected |
| Standby antibiotic — fever onset | Amoxicillin/clavulanate 875/125 mg BID × 5–7 days | Levofloxacin 500 mg daily × 5–7 days | Patient must still seek urgent review — not a substitute for assessment |
| Travel cover | Same as standby — carry in original packaging | Same as standby (levofloxacin) | Add malaria prophylaxis where appropriate; OPSI is more severe in asplenic travellers |
| Animal/human bite | Amoxicillin/clavulanate 875/125 mg BID × 5 days | Doxycycline 100 mg BID + metronidazole 400 mg TID | Cover Capnocytophaga canimorsus — particularly virulent in asplenia |
OPSI Recognition and Patient Counselling
Overwhelming post-splenectomy infection is a clinical emergency. The prodrome is often non-specific — mild flu-like symptoms, low-grade fever, malaise — followed by rapid progression to septic shock and disseminated intravascular coagulation within 12–48 hours. The window for life-saving antibiotic administration is narrow, which is why patient counselling sits at the centre of every post-splenectomy care pathway.
Every asplenic patient should leave their pre-discharge consultation with three things: a clear understanding of the warning signs (sepsis recognition red flags), a written action plan, and the standby antibiotics in hand. Verbal counselling alone is not enough.
Counsel patients to take the standby antibiotic immediately and seek emergency care for any fever above 38°C, rigors, severe sore throat with neck stiffness, abdominal pain, or unexplained malaise.
Strong Rec High Evidence BSH 2011Provide a medical alert card or bracelet stating the patient is asplenic, including current prophylactic medication and emergency contact for their treating clinician.
Strong Rec Low Evidence BSH 2011Document asplenic status prominently in the electronic medical record, the family physician handover letter, and on the patient’s prescription list.
Strong Rec Low Evidence BSH 2011OPSI Warning Signs and Patient Action Plan
| Warning Sign | Patient Action | Common Pitfall to Address in Counselling |
|---|---|---|
| Fever ≥38°C or rigors | Take standby antibiotic immediately, attend emergency department | Patients often wait to see if fever resolves — emphasise act-first principle |
| Severe sore throat with neck stiffness | Take standby antibiotic, call emergency services | Easily dismissed as a routine viral illness — teach the meningitis combination |
| Petechial or purpuric rash | Treat as septic emergency — call emergency services first | Patients may not recognise the rash — show them photographs in clinic |
| Severe rigors without fever yet | Take standby antibiotic, attend emergency department | Rigors precede fever in OPSI — do not wait for the thermometer |
| Animal bite, scratch, or tick exposure | Take standby antibiotic and arrange same-day medical review | Trivialised injuries from family pets cause many OPSI cases |
| Travel to malaria-endemic region | Pre-travel: malaria prophylaxis, additional vaccines, written action plan in destination language | Asplenic patients have higher malaria mortality — strict adherence required |
Clinical Decision Pathway
A practical, question-based approach to structuring post-splenectomy care from referral through long-term follow-up.
Long-Term Post-Splenectomy Care and Monitoring
Lifelong follow-up is integral to post-splenectomy care because immunological vulnerability persists and vaccine-induced antibody titres wane. Most failures of post-splenectomy care happen years later, when boosters are missed and the patient assumes — incorrectly — that initial vaccination provides permanent protection.
Refer asplenic patients to travel medicine at least 6–8 weeks before international travel for malaria prophylaxis, additional vaccines, and destination-specific risk counselling.
Strong Rec Moderate Evidence BSH 2011Reassess annually: confirm adherence to prophylaxis, review booster schedule, refresh OPSI counselling, and check that the medical alert card or bracelet is current.
Strong Rec Low Evidence BSH 2011Counsel pregnant asplenic patients carefully: continue antibiotic prophylaxis, use only inactivated vaccines, and arrange shared care with obstetrics and infectious disease.
Moderate Rec Low Evidence BSH 2011Do not rely on antibody titres to guide booster timing in asplenia. Use the fixed scheduled approach instead because titre cut-offs for protective immunity are not standardised.
Against Low Evidence BSH 2011Long-Term Monitoring Schedule
| Time Point | What to Check | Action if Issue Found | Common Failure Mode |
|---|---|---|---|
| Discharge | Vaccines documented, standby antibiotic in hand, alert card issued | Do not discharge until all three are complete | Weekend discharges with pharmacy closures |
| 6 weeks | Wound healing, adherence to prophylaxis, post-emergency vaccination completion | Re-counsel; address adherence barriers | Patients stop antibiotics once they feel well |
| 8 weeks (if PCV15 sequence) | Administer PPSV23 dose | Schedule before discharge to avoid loss to follow-up | PPSV23 omitted in transitions of care |
| Annual | Influenza vaccine, OPSI counselling refresh, alert card update | Reissue standby antibiotic if expired | Expired standby packs in patient’s drawer |
| Every 5 years | MenACWY booster; PPSV23 single booster (if applicable) | Catch up at the next clinical contact | Five-year reminders are often missed in EMRs |
| Every 2–3 years | MenB booster per local product guidance | Match brand to original priming series | Mixing 4CMenB and MenB-FHbp products |
Evidence in Context
Where the major bodies agree, where they diverge, and what high-quality observational data adds to current post-splenectomy care frameworks.
Where BSH, IDSA, and ACIP Agree
All three frameworks converge on the central elements of post-splenectomy care: pneumococcal, meningococcal, and Hib vaccination is mandatory in asplenia; pre-operative vaccination is preferred; antibiotic prophylaxis has a role; and structured patient counselling is essential. They agree on the day-14 post-operative window for emergency cases and on the need for medical alert documentation.
Where the Guidelines Differ on Lifelong Antibiotic Prophylaxis
British guidance (BSH 2011) favours lifelong prophylaxis for higher-risk adults; American guidance from IDSA is more conservative, often recommending 2–3 years of prophylaxis for adults without additional risk factors. Both agree on lifelong therapy for children, prior OPSI, or active haematological disease. The divergence reflects a real evidence gap — no randomised trial has compared lifelong versus time-limited adult prophylaxis.
PCV20 versus PCV15 + PPSV23: What the Evidence Shows
The 2023 ACIP update introduced PCV20 as a single-dose alternative to the older PCV15-then-PPSV23 sequence. PCV20 covers fewer serotypes than the combined sequence but simplifies adherence and reduces missed doses. Either approach is acceptable in asplenia; pick based on the local cold chain, patient preference, and likelihood of completing a second visit. In settings where PPSV23 follow-up is unreliable, single-dose PCV20 is the pragmatic post-splenectomy care choice.
OPSI Mortality Has Fallen but Remains Substantial
A population-based review by Theilacker and colleagues (2016) reported case-fatality rates between 38% and 70% across older series, with newer cohorts showing improvement in centres with structured post-splenectomy care pathways. Mortality reductions correlate with three elements: same-day antibiotic administration, broader vaccine uptake, and improved patient recognition of warning signs.
Why Adherence to Daily Prophylaxis Falls Over Time
Observational data show prophylaxis adherence declining from roughly 80% at year 1 to 30% by year 3 in adults. The drivers are predictable: feeling well, concerns about resistance, side effects, and forgetting. Building the standby antibiotic into the plan ensures protection persists even when daily adherence falters — a structural redundancy worth emphasising during every annual review.
References
- 1.Davies JM, Lewis MP, Wimperis J, Rafi I, Ladhani S, Bolton-Maggs PH. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology. Br J Haematol. 2011;155(3):308–317. doi:10.1111/j.1365-2141.2011.08843.x
- 2.Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44–e100. doi:10.1093/cid/cit684
- 3.Kobayashi M, Pilishvili T, Farrar JL, et al. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023. MMWR Recomm Rep. 2023;72(3):1–37. doi:10.15585/mmwr.rr7203a1
- 4.Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1–41. doi:10.15585/mmwr.rr6909a1
- 5.Theilacker C, Ludewig K, Serr A, et al. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. Clin Infect Dis. 2016;62(7):871–878. doi:10.1093/cid/civ1031
How to Read the Evidence Tags
Every recommendation in this article carries two tags showing recommendation strength and evidence quality. These are Medaptly’s own simplified interpretations — readers should consult the original guidelines for full grading definitions.
Recommendation Strength
| Tag | What It Means |
|---|---|
| Strong Rec | High-quality evidence broadly supports this action across major guidelines. |
| Moderate Rec | The weight of evidence favours this action. |
| Conditional Rec | The benefit is less certain — individualise to the patient. |
| Against | Evidence shows no benefit or potential harm. |
Evidence Quality
| Tag | What It Means |
|---|---|
| High Evidence | Multiple well-designed RCTs or high-quality meta-analyses. |
| Moderate Evidence | Single RCT or large observational cohort studies. |
| Low Evidence | Expert consensus, small studies, or extrapolation from related populations. |